News Releases

News & Events

News Releases

Synteract Exhibiting and Presenting on Electronic Data Capture at Outsourcing in Clinical Trials Southeast Conference

Participation in other spring conferences to include Annual EuroMeeting in Paris and ACRP in Salt Lake City

SAN DIEGO – March 12, 2015 – Synteract, a full-service, international contract research organization (CRO), will participate in and present at the 4th Annual Outsourcing in Clinical Trials Southeast conference in Cary, North Carolina from March 24-25. Members of Synteract’s senior leadership team as well as staff from the company’s Research Triangle Park office will be in attendance. 

Director, Global Vendor Management, Toby Odenheim will present “Selecting the Optimum EDC Platform to Support Your Clinical Program” at 12:00 p.m. on Tuesday, March 24. In today’s globalized marketplace, the clinical research industry is challenged to make the drug development process more efficient. There is an increased urgency to have the right electronic data capture (EDC) platform in place from protocol development to delivery. Attendees will learn a systematic approach to evaluate EDC platforms so they can select the best vendor to collect clinical trial data. Odenheim previously presented on EDC at DIA 2014.

OCT Southeast provides a forum for biotech and pharma companies and CROs to discuss outsourcing partnerships in the Southeast region and particularly the Research Triangle Park area, which is viewed as one of the top biotech hubs in the world. To set an appointment with the Synteract team in advance, contact Business Development Director Erin Tabet at 919.674.8042 or

In April, Synteract will also attend the 27th Annual EuroMeeting in Paris and will exhibit at the ACRP 2015 Global Conference & Exhibition in Salt Lake City at booth #418. See the company’s full schedule of events online, and follow its social channels on LinkedIn and Twitter for live updates during all drug development and clinical research conferences this spring.

About Synteract
Synteract is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Synteract has conducted Phase I-IV studies on six continents and in more than 60 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, Synteract provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.

Amanda Whitlock


Contact Synteract

Tell us how to stay in touch with you: